CLRB Cellectar Biosciences, Inc.
$1.21▼ -0.82%
Healthcare
Other
Volume 183.8K
Avg Volume (10D) 239.8K
Key Metrics & Fundamentals
Market Cap
$11.44M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.12 - 4.70
% vs 50 MA
-39.35%
% vs 200 MA
-54.88%
RSI-14
28.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.66
Free Cash Flow
-$6.01M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.29M
COGS
–
Operating Exp
$7.20M
Operating Income
-$7.20M
EBIT
-$7.20M
Pretax Income
-$6.93M
Net Income
-$6.93M
EPS (Diluted)
-0.57
Price & Volume History
Loading chart…
Recent News
Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia
GlobeNewswire · Oct 15, 2026 7:00 AM ET
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia
GlobeNewswire · Sep 29, 2026 7:30 AM ET
Cellectar Biosciences (CLRB) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 10:13 AM ET
Cellectar Biosciences Inc (CLRB) (Q2 2026) Earnings Call Highlights: Strong Clinical Data and ...
GuruFocus.com · Aug 17, 2026 5:02 PM ET
Cellectar Biosciences, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 9:03 PM ET
Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
GlobeNewswire · Aug 13, 2026 7:15 AM ET
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
GlobeNewswire · Jul 30, 2026 8:05 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CLRB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.